Process

The cancer detection industry is undergoing rapid transformation, driven by demand for earlier diagnosis, multi-cancer technologies, and AI integration. This article explores the trends shaping the field, from liquid biopsy development to accessibility challenges, and highlights how SpotitEarly addresses these gaps. With a bio-AI breath test platform detecting VOCs at early stages, SpotitEarly combines accuracy, accessibility, and transparency to help lead the cancer detectio

Data privacy is central to SpotitEarly’s mission. As a HIPAA-compliant company, we implement strict safeguards to protect every piece of patient information, from breath sample analysis to medical background and AI-driven results. This article outlines how our layered approach combines encrypted storage, secure databases, strict access controls, and continuous monitoring. At SpotitEarly, innovative cancer detection goes hand in hand with rigorous healthcare data protection.

SpotitEarly’s LUCID bio-hybrid platform unites the natural sensitivity of trained detection dogs with the precision of artificial intelligence. This article explores how the system captures and analyzes breath samples, integrates biological and technological strengths, and delivers accurate, scalable early cancer detection. Learn how LUCID is redefining what’s possible in non-invasive cancer screening.

The recent Rainbow clinical study, published in Nature Scientific Reports, showcases SpotitEarly’s extraordinary success. It shows SpotitEarly is able to detect cancer at early stages with sensitivity rates exceeding 90% for multiple cancers, including those with no standard screening options available today. This breakthrough positions SpotitEarly as a world leader in early disease detection technology.

Artificial intelligence is at the core of SpotitEarly’s bio-hybrid AI platform, refining and validating results from canine scent detection to ensure accuracy and scalability. This article explores how AI models process complex data, integrate it with clinical workflows, and evolve it over time. By combining canine’s abilities with cutting-edge machine learning, SpotitEarly aims to make early cancer screening more precise, accessible, and widely adopted.

Dogs possess an extraordinary sense of smell — capable of detecting volatile organic compounds linked to cancer at concentrations humans cannot perceive. This article will explain the biology of canine olfaction, the research behind scent-based cancer detection, and how SpotitEarly plans to train dogs as part of a hybrid platform with AI to make early, non-invasive cancer screening possible on a global scale.

At SpotitEarly, we are transforming the way cancer screening works, making it more accessible, accurate and user-friendly. Our innovative breath test is designed to detect cancer early, when survival rates are highest and treatment is most effective. But what will the full testing process look like for patients?